Foscarnet - Revision history

Danbot: Restore original dosing content alongside dynamic SMW tables

2026-03-20T02:38:47Z

Restore original dosing content alongside dynamic SMW tables

← Revisión anterior		Revisión del 02:38 20 mar 2026
Línea 6:		Línea 6:

	==Adult Dosing==		==Adult Dosing==
			*CMV retinitis: 90 mg/kg IV q12h '''OR''' 60 mg/kg IV q8h for 2-3 weeks, then maintenance 90-120 mg/kg IV daily
			*HSV resistant to acyclovir, immunocompromised: 40 mg/kg IV 2-3 times daily
			*VZV resistant to acyclovir, HIV+: 90 mg/kg IV q12h

	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Foscarnet]] [[Has Population::Adult]]		{{#ask: [[Has DrugName::Foscarnet]] [[Has Population::Adult]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

	==Pediatric Dosing==		==Pediatric Dosing==


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Foscarnet]] [[Has Population::Pediatric]]		{{#ask: [[Has DrugName::Foscarnet]] [[Has Population::Pediatric]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

Danbot: Replace manual dosing with dynamic SMW tables (Adult + Pediatric)

2026-03-20T01:52:46Z

Replace manual dosing with dynamic SMW tables (Adult + Pediatric)

@@ Línea 6: / Línea 6: @@
 ==Adult Dosing==
-*CMV retinitis: 90 mg/kg IV q12h '''OR''' 60 mg/kg IV q8h for 2-3 weeks, then maintenance 90-120 mg/kg IV daily
+===Indications by Disease===
-*HSV resistant to acyclovir, immunocompromised: 40 mg/kg IV 2-3 times daily
+{{#ask: [[Has DrugName::Foscarnet]] [[Has Population::Adult]]
-*VZV resistant to acyclovir, HIV+: 90 mg/kg IV q12h
+|?Treats disease=Disease
 ==Pediatric Dosing==
 ==Special Populations==

ClaireLewis: /* References */

2019-09-22T20:02:04Z

References

← Revisión anterior		Revisión del 20:02 22 sep 2019
Línea 50:		Línea 50:
	<references/>		<references/>
	[[Category:Pharmacology]]		[[Category:Pharmacology]]
			[[Category:ID]]

Mholtz: Text replacement - "OR" to "'''OR'''"

2017-05-30T21:10:40Z

Text replacement - "OR" to "'''OR'''"

← Revisión anterior		Revisión del 21:10 30 may 2017
Línea 6:		Línea 6:

	==Adult Dosing==		==Adult Dosing==
	*CMV retinitis: 90 mg/kg IV q12h OR 60 mg/kg IV q8h for 2-3 weeks, then maintenance 90-120 mg/kg IV daily		*CMV retinitis: 90 mg/kg IV q12h '''OR''' 60 mg/kg IV q8h for 2-3 weeks, then maintenance 90-120 mg/kg IV daily
	*HSV resistant to acyclovir, immunocompromised: 40 mg/kg IV 2-3 times daily		*HSV resistant to acyclovir, immunocompromised: 40 mg/kg IV 2-3 times daily
	*VZV resistant to acyclovir, HIV+: 90 mg/kg IV q12h		*VZV resistant to acyclovir, HIV+: 90 mg/kg IV q12h

ClaireLewis: /* Administration */

2017-02-25T23:09:12Z

Administration

← Revisión anterior		Revisión del 23:09 25 feb 2017
Línea 1:		Línea 1:
	==Administration==		==Administration==
	*Type: Antiviral		*Type: [[Antiviral]]
	*Dosage Forms:		*Dosage Forms:
	*Routes of Administration: IV		*Routes of Administration: IV

ClaireLewis: Created page with "==Administration== Type: Antiviral Dosage Forms: Routes of Administration: IV Common Trade Names: Foscavir ==Adult Dosing== *CMV retinitis: 90 mg/kg IV q12h OR 60 mg/kg I..."

2016-10-09T22:50:50Z

Created page with "==Administration== *Type: Antiviral *Dosage Forms: *Routes of Administration: IV *Common Trade Names: Foscavir ==Adult Dosing== *CMV retinitis: 90 mg/kg IV q12h OR 60 mg/kg I..."

Página nueva

==Administration==
*Type: Antiviral
*Dosage Forms:
*Routes of Administration: IV
*Common Trade Names: Foscavir

==Adult Dosing==
*CMV retinitis: 90 mg/kg IV q12h OR 60 mg/kg IV q8h for 2-3 weeks, then maintenance 90-120 mg/kg IV daily
*HSV resistant to acyclovir, immunocompromised: 40 mg/kg IV 2-3 times daily
*VZV resistant to acyclovir, HIV+: 90 mg/kg IV q12h
==Pediatric Dosing==

==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C
*[[Lactation risk categories|Lactation risk]]: Infant risk cannot be ruled out
*Renal dosing: Complicated dose adjustment required!
*Hepatic dosing: No adjustement

==Contraindications==
*Allergy to class/drug

==Adverse Reactions==
===Serious===
*Hyperphosphatemia, hypophosphatemia, hypocalcemia, hypokalemia, hypomagnesemia
*Pancreatitis
*Pancytopenia
*Renal failure, renal impairment
*Seizure
===Common===
*Nausea, vomiting, diarrhea
*Anemia, granulocytopenic disorder
*Headache
*Fever

==Pharmacology==
*Half-life: 3.3-4h
*Metabolism:
*Excretion: Renal

==Mechanism of Action==
*inhibits pyrophosphate binding on viral DNA polymerases

==Comments==

==See Also==
*[[CMV]]
*[[HSV]]
*[[Immunocompromised antibiotics]]
==References==
<references/>
[[Category:Pharmacology]]